USE OF SEMAPHORIN 3A FOR DIAGNOSING AND TREATING CANCER, ESPECIALLY PROSTATE CANCER

摘要

The invention relates to a method for in vitro evaluation of the aggressiveness of tumoral cells by measuring the level of expression of all or part of a gene coding for semaphorin 3A in healthy epithelial cells and in epithelial tumoral cells. The invention also relates to a method for inhibiting the invasive power of said epthilelial tumoral cells, consisting in increasing the levels of semaphorin 3A levels present in and/or in the vicinity of said epithelial tumoral cells.